Terconazole Suppository
Product Images NDC 51672-1330

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terconazole (NDC 51672-1330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Terconazole 01)

Chemical structure of Terconazole. The diagram shows the molecular arrangement of Terconazole, including its heterocyclic rings and chlorine-substituted aromatic groups.*

FDA Label Image

Figure (Terconazole 02)

An instructional line drawing showing two hands holding a single vaginal suppository, likely demonstrating handling or insertion technique for Terconazole 80 mg vaginal suppository by Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Figure (Terconazole 03)

An instructional illustration showing hands preparing a Terconazole vaginal suppository using an applicator tube. One hand is holding the tube, and the other is inserting or positioning the suppository inside the applicator for vaginal insertion.*

FDA Label Image

Figure (Terconazole 04)

An instructional diagram showing female genital anatomy with labeled urinary opening, vagina, and rectum, illustrating the anatomical sites relevant for vaginal suppository insertion.*

FDA Label Image

Figure (Terconazole 05)

An illustration showing a hand holding a vaginal suppository, demonstrating the product's form and general method of handling for insertion.*

FDA Label Image

Principal Display Panel (80 mg Dose Pack Carton)

Packaging label for Terconazole Vaginal Suppositories 80 mg, containing 3 suppositories with a vaginal applicator. The label includes storage instructions, manufacturer information (Taro Pharmaceuticals), NDC 51672-1330-3, and warnings to keep out of reach of children. The design features a red vertical stripe and the TARO logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.